Case 472 · ICHD-3 7.3.3
7.3.3 Headache attributed to other non-infectious inflammatory intracranial disease
- Origin
- Synthetic
- Language
- English — also available in German
- Contributed by
- Imported case — HeadAI synthetic vignettes (de Andrade JBC, da Silva Costa TB, Vasconcelos JL, Lopes TLM, Balsells MD, Cristofolini VL, Querobin SO, Filho FMR. Validation of an AI-based platform for structured diagnosis of headache disorders using ICHD-3 criteria. BMC Neurology 25, 489 (2025). doi:10.1186/s12883-025-04473-1. Dataset: Andrade J. Head.AI Platform. Mendeley Data, V2 (2025). doi:10.17632/4fms6cw2s5.2)
Anamnesis
Identification: Sex/Age: Male, 42 years
History: Pulmonary sarcoidosis diagnosed 2 years ago, on methotrexate 15mg/week
Current Medications: Methotrexate, folic acid
History of Present Illness (HPI): Main symptom: Holocranial headache for 3 weeks
Pain characteristics:
Onset: Gradual
Character: Constant pressure
Intensity: 6-7/10
Aggravation: Progressive worsening, no response to NSAIDs
Associated symptoms:
Intermittent double vision
Bilateral tinnitus
Weakness in the right lower limb
Relevant factors: History of sarcoidosis with possible CNS involvement
Physical/Neurological Examination: General: Preserved consciousness
Neurological:
Partial paralysis of the left sixth cranial nerve
Hypoesthesia in the right hemibody
Brisk reflexes in the right lower limb
Ataxic gait
Complementary Exams: Cranial MRI:
Granulomatous meningitis with leptomeningeal enhancement in the posterior fossa
Multiple periventricular parenchymal lesions
CSF:
Lymphocytosis (50 cells/mm³)
Elevated proteins (120 mg/dL)
Normal glucose
Elevated ACE (8.2 U/L)
Negative cultures
Laboratory:
Elevated serum ACE (65 ng/mL)
Elevated CRP and ESR
Report this case — e.g. suspected re-identification risk.